RNA m1A Methyltransferase TRMT6 Predicts Poorer Prognosis and Promotes Malignant Behavior in Glioma
Background: Glioma is the most prevalent central nervous system tumor in humans, and its prognosis remains unsatisfactory due to a lack of effective therapeutic targets. The ectopic expression of N1-methyladenosine (m1A) regulators is a key participant in tumorigenesis and progression. However, the...
Main Authors: | Beibei Wang, Lihua Niu, Zhengyang Wang, Zhihua Zhao |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-09-01
|
Series: | Frontiers in Molecular Biosciences |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmolb.2021.692130/full |
Similar Items
-
The Common Partner of Several Methyltransferases TRMT112 Regulates the Expression of N6AMT1 Isoforms in Mammalian Cells
by: Lilian Leetsi, et al.
Published: (2019-08-01) -
Analysis of the factors affecting the prognosis of glioma patients
by: Wang Jiancun, et al.
Published: (2019-04-01) -
Identification of 3 subpopulations of tumor-infiltrating immune cells for malignant transformation of low-grade glioma
by: Jiacheng Lu, et al.
Published: (2019-10-01) -
m<sup>5</sup>U54 tRNA Hypomodification by Lack of TRMT2A Drives the Generation of tRNA-Derived Small RNAs
by: Marisa Pereira, et al.
Published: (2021-03-01) -
Differential resting-state patterns across networks are spatially associated with Comt and Trmt2a gene expression patterns in a mouse model of 22q11.2 deletion
by: Natalia Gass, et al.
Published: (2021-11-01)